Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charalampos Moschos

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Cytokine|May 11, 2013
Interleukin-18 is up-regulated in infectious pleural effusionsNikoletta Rovina, Efrossini Dima, Ioannis Psallidas, et al.
Oncotarget|March 10, 2016
Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusionSophia Magkouta, Apostolos Pappas, Charalampos Moschos, et al.
Respirology (Carlton, Vic.)|August 7, 2015
Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivoMaria Eleni Vazakidou, Sophia Magkouta, Charalampos Moschos, et al.
Respirology (Carlton, Vic.)|December 15, 2012
Interleukin-17A is involved in bacteria-related acute pleural inflammationAndroniki Kollintza, Sofia Magkouta, Ioannis Psallidas, et al.
Respirology (Carlton, Vic.)|May 30, 2009
Osteopontin is upregulated in malignant and inflammatory pleural effusionsCharalampos Moschos, Ilias Porfiridis, Ioannis Psallidas, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2011
A sulindac analogue is effective against malignant pleural effusion in miceCharalampos Moschos, Ioannis Psallidas, Thomas Cottin, et al.
Cytokine|September 12, 2018
Role of angiopoietins in mesothelioma progressionSophia Magkouta, Androniki Kollintza, Charalampos Moschos, et al.
Respirology (Carlton, Vic.)|January 17, 2008
Pneumothorax-associated pleural eosinophilia is tumour necrosis factor-alpha-dependent and attenuated by steroidsIoannis Kalomenidis, Charalampos Moschos, Androniki Kollintza, et al.
Oncotarget|May 19, 2018
Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implicationsSophia Magkouta, Apostolos Pappas, Ioannis S Pateras, et al.
Oncoimmunology|February 5, 2019
Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growthApostolos G Pappas, Sophia Magkouta, Ioannis S Pateras, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Cytokine|May 11, 2013
Interleukin-18 is up-regulated in infectious pleural effusionsNikoletta Rovina, Efrossini Dima, Ioannis Psallidas, et al.
Oncotarget|March 10, 2016
Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusionSophia Magkouta, Apostolos Pappas, Charalampos Moschos, et al.
Respirology (Carlton, Vic.)|August 7, 2015
Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivoMaria Eleni Vazakidou, Sophia Magkouta, Charalampos Moschos, et al.
Respirology (Carlton, Vic.)|December 15, 2012
Interleukin-17A is involved in bacteria-related acute pleural inflammationAndroniki Kollintza, Sofia Magkouta, Ioannis Psallidas, et al.
Respirology (Carlton, Vic.)|May 30, 2009
Osteopontin is upregulated in malignant and inflammatory pleural effusionsCharalampos Moschos, Ilias Porfiridis, Ioannis Psallidas, et al.
Lung Cancer (Amsterdam, Netherlands)|January 14, 2011
A sulindac analogue is effective against malignant pleural effusion in miceCharalampos Moschos, Ioannis Psallidas, Thomas Cottin, et al.
Cytokine|September 12, 2018
Role of angiopoietins in mesothelioma progressionSophia Magkouta, Androniki Kollintza, Charalampos Moschos, et al.
Respirology (Carlton, Vic.)|January 17, 2008
Pneumothorax-associated pleural eosinophilia is tumour necrosis factor-alpha-dependent and attenuated by steroidsIoannis Kalomenidis, Charalampos Moschos, Androniki Kollintza, et al.
Oncotarget|May 19, 2018
Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implicationsSophia Magkouta, Apostolos Pappas, Ioannis S Pateras, et al.
Oncoimmunology|February 5, 2019
Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growthApostolos G Pappas, Sophia Magkouta, Ioannis S Pateras, et al.
Pageof 3